Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CEDOSE: High vs Low Dose ESA in Hemodialysis
NCT00827021Phase 3Completed
- Start
- Jul 2009
- Primary completion
- Jul 2014
- Modality
- Erythropoietins, Colony Stimulating Factors
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of epoetin alfa and epoetin beta in anemia of chronic kidney disease (CKD-A) (2 arms). Primary endpoints: Transferrin Saturation at 12 months, Serum Albumin at 12 months and 3 more. Started Jul 2009; status: completed.
02
Drugs
epoetin alfaepoetin beta
03
Conditions
anemia of chronic kidney disease (CKD-A)
Beyond the preview
Go deeper on NCT00827021.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00827021.